These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12115810)

  • 1. Pharmacokinetics and tissue distribution after intravenous administration of a single dose of amphotericin B cochleates, a new lipid-based delivery system.
    Segarra I; Movshin DA; Zarif L
    J Pharm Sci; 2002 Aug; 91(8):1827-37. PubMed ID: 12115810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative drug disposition, urinary pharmacokinetics, and renal effects of multilamellar liposomal nystatin and amphotericin B deoxycholate in rabbits.
    Groll AH; Mickiene D; Petraitis V; Petraitiene R; Alfaro RM; King C; Piscitelli SC; Walsh TJ
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3917-25. PubMed ID: 14638502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma protein binding of amphotericin B and pharmacokinetics of bound versus unbound amphotericin B after administration of intravenous liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate.
    Bekersky I; Fielding RM; Dressler DE; Lee JW; Buell DN; Walsh TJ
    Antimicrob Agents Chemother; 2002 Mar; 46(3):834-40. PubMed ID: 11850269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disposition and tissue distribution of imatinib in a liposome formulation after intravenous bolus dose to mice.
    Moo KS; Radhakrishnan S; Teoh M; Narayanan P; Bukhari NI; Segarra I
    Yao Xue Xue Bao; 2010 Jul; 45(7):901-8. PubMed ID: 20931790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiologically based pharmacokinetic model of amphotericin B disposition in rats following administration of deoxycholate formulation (Fungizone®): pooled analysis of published data.
    Kagan L; Gershkovich P; Wasan KM; Mager DE
    AAPS J; 2011 Jun; 13(2):255-64. PubMed ID: 21431453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of orally delivered cochleates containing amphotericin B in a murine model of aspergillosis.
    Delmas G; Park S; Chen ZW; Tan F; Kashiwazaki R; Zarif L; Perlin DS
    Antimicrob Agents Chemother; 2002 Aug; 46(8):2704-7. PubMed ID: 12121962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative pharmacokinetics and safety of a novel lyophilized amphotericin B lecithin-based oil-water microemulsion and amphotericin B deoxycholate in animal models.
    Brime B; Frutos P; Bringas P; Nieto A; Ballesteros MP; Frutos G
    J Antimicrob Chemother; 2003 Jul; 52(1):103-9. PubMed ID: 12805269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in tissue drug concentrations following intravenous versus intraperitoneal treatment with amphotericin B deoxycholate or liposomal amphotericin B.
    Chang T; Olson JA; Proffitt RT; Adler-Moore JP
    Med Mycol; 2010 Mar; 48(2):430-5. PubMed ID: 20141377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics, excretion, and mass balance of liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate in humans.
    Bekersky I; Fielding RM; Dressler DE; Lee JW; Buell DN; Walsh TJ
    Antimicrob Agents Chemother; 2002 Mar; 46(3):828-33. PubMed ID: 11850268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics in rats of n-dimethylaminoacetyl-partricin a 2-dimethylaminoethylamide diascorbate (spk-843).
    Bruzzese T; Galmozzi MR; Buffa G; Sala P; Bonabello A
    Chemotherapy; 2001; 47(2):77-85. PubMed ID: 11173807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of amphotericin B lipid complex in critically ill patients undergoing continuous venovenous haemodiafiltration.
    Malone ME; Corrigan OI; Kavanagh PV; Gowing C; Donnelly M; D'Arcy DM
    Int J Antimicrob Agents; 2013 Oct; 42(4):335-42. PubMed ID: 23920093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compartmentalized intrapulmonary pharmacokinetics of amphotericin B and its lipid formulations.
    Groll AH; Lyman CA; Petraitis V; Petraitiene R; Armstrong D; Mickiene D; Alfaro RM; Schaufele RL; Sein T; Bacher J; Walsh TJ
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3418-23. PubMed ID: 17005824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition of aerosolized liposomal amphotericin B.
    Lambros MP; Bourne DW; Abbas SA; Johnson DL
    J Pharm Sci; 1997 Sep; 86(9):1066-9. PubMed ID: 9294824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compartmental pharmacokinetics and tissue distribution of the antifungal echinocandin lipopeptide micafungin (FK463) in rabbits.
    Groll AH; Mickiene D; Petraitis V; Petraitiene R; Ibrahim KH; Piscitelli SC; Bekersky I; Walsh TJ
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3322-7. PubMed ID: 11709303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amphotericin B lipid complex or amphotericin B multiple-dose administration to rabbits with elevated plasma cholesterol levels: pharmacokinetics in plasma and blood, plasma lipoprotein levels, distribution in tissues, and renal toxicities.
    Ramaswamy M; Peteherych KD; Kennedy AL; Wasan KM
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1184-91. PubMed ID: 11257033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic-pharmacodynamic comparison of amphotericin B (AMB) and two lipid-associated AMB preparations, liposomal AMB and AMB lipid complex, in murine candidiasis models.
    Andes D; Safdar N; Marchillo K; Conklin R
    Antimicrob Agents Chemother; 2006 Feb; 50(2):674-84. PubMed ID: 16436726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro pharmacodynamics of rapid versus continuous infusion of amphotericin B deoxycholate against Candida species in the presence of human serum albumin.
    Lewis RE; Wiederhold NP; Prince RA; Kontoyiannis DP
    J Antimicrob Chemother; 2006 Feb; 57(2):288-93. PubMed ID: 16387749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
    Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
    Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heat-induced reformulation of amphotericin B-deoxycholate favours drug uptake by the macrophage-like cell line J774.
    Chéron M; Petit C; Bolard J; Gaboriau F
    J Antimicrob Chemother; 2003 Dec; 52(6):904-10. PubMed ID: 14613963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corneal concentrations following systemic administration of amphotericin B and its lipid preparations in a rabbit model.
    Goldblum D; Rohrer K; Frueh BE; Theurillat R; Thormann W; Zimmerli S
    Ophthalmic Res; 2004; 36(3):172-6. PubMed ID: 15103209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.